Early Detection of Genetic Disorders for Lifelong Health
The IDNGS™ Newborn Genetic Screening Panel is a comprehensive Next-Generation Sequencing (NGS)-based test designed to detect a wide range of inherited genetic disorders in newborns. This panel enables early diagnosis of conditions that may not show symptoms at birth but can significantly affect a child’s development and long-term health if left untreated.
By screening for mutations across multiple clinically relevant genes, this test supports timely medical intervention, helping improve outcomes through early treatment and care.
Screens for 100+ genetic conditions including metabolic, endocrine, immune, and neurological disorders
Detects SNVs, indels, and other pathogenic variants
Uses whole blood or dried blood spot (DBS) samples
Helps enable early diagnosis, treatment, and genetic counseling
Reduces the risk of delayed development and disability
Complies with ACMG guidelines and developed under ISO 13485 standards
| Parameter | Details |
|---|---|
| Panel Name | IDNGS™ Newborn Genetic Screening Panel |
| Technology | Targeted Next-Generation Sequencing (NGS) |
| Sample Type | Whole blood or Dried Blood Spot (DBS) |
| Genes Covered | 100+ clinically relevant genes |
| Variant Types Detected | SNVs, Indels, Pathogenic mutations |
| Turnaround Time | 10–14 working days |
| Clinical Use | Early detection and management of inherited genetic disorders |
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.